Andrew Song

机构：Merck & Co., Inc., Rahway, NJ, USA (United States), Harvard University, Wuhan University, Massachusetts General Hospital, Hebrew SeniorLife, Nanjing Medical University · ORCID：0000-0001-8386-4397

发表论文 80 篇 · 总被引 741 次 · h-index 14

代表论文

• Scalp-Sparing Radiation With Concurrent Temozolomide and Tumor Treating Fields (SPARE) for Patients With Newly Diagnosed Glioblastoma (2022 · Frontiers in Oncology · 被引 36)
• Is Timing of Steroid Exposure Prior to Immune Checkpoint Inhibitor Initiation Associated with Treatment Outcomes in Melanoma? A Population-Based Study (2022 · Cancers · 被引 21)
• LEAP-008: Lenvatinib Plus Pembrolizumab for Metastatic NSCLC That Has Progressed After an Anti–Programmed Cell Death Protein 1 or Anti–Programmed Cell Death Ligand 1 Plus Platinum Chemotherapy (2025 · Journal of Thoracic Oncology · 被引 18)
• Affordable IgY-based antiviral prophylaxis for resource-limited settings to address epidemic and pandemic risks (2022 · Journal of Global Health · 被引 18)
• A portable photoacoustic microscopy and ultrasound system for rectal cancer imaging (2024 · Photoacoustics · 被引 16)
• Long-Term Outcomes of Surgery and Radiation Treatment for Adult Patients with Craniopharyngioma (2024 · World Neurosurgery · 被引 11)